GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Nutritional Disorders market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Nutritional Disorders market reports here.

NEW Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hyperphosphatemia pipeline landscape. The report provides comprehensive information on the therapeutics...

Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

  • $2,000
  • December 2021
Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease - Drugs In Development, 2021’, provides an overview of the Hyperphosphatemia In Hyperphosphatemia In Chronic Kidney Disease pipeline landscape. The report provides...

Hyperphosphatemia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • September 2021
GlobalData's clinical trial report, “Hyperphosphatemia - Global Clinical Trials Review, H2, 2021" provides an overview of Hyperphosphatemia Clinical trials scenario. This report provides top line data relating to the clinical...

Hyperphosphatemia – Global Clinical Trials Review, H1, 2021

  • $2,500
  • March 2021
GlobalData's clinical trial report, “Hyperphosphatemia - Global Clinical Trials Review, H1, 2021" provides an overview of Hyperphosphatemia Clinical trials scenario. This report provides top line data relating to the clinical...

Avitaminosis (Hypovitaminosis) Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • December 2020
GlobalData's clinical trial report, “Avitaminosis (Hypovitaminosis) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Avitaminosis (Hypovitaminosis) Clinical trials scenario. This report provides top line data relating...

Malnutrition – Global Clinical Trials Review, H2, 2020

  • $2,500
  • October 2020
GlobalData's clinical trial report, “Malnutrition Global Clinical Trials Review, H2, 2020" provides an overview of Malnutrition Clinical trials scenario. This report provides top line data relating to the clinical trials...

Hypercalcemia Disease – Global Clinical Trials Review, H2 2020

  • $2,500
  • October 2020
GlobalData's clinical trial report, “Hypercalcemia Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hypercalcemia Clinical trials scenario. This report provides top line data relating to the...

Hyponatremia Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • September 2020
GlobalData's clinical trial report, “Hyponatremia Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hyponatremia Clinical trials scenario. This report provides top line data relating to the...

Hyperphosphatemia Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • September 2020
GlobalData's clinical trial report, “Hyperphosphatemia Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hyperphosphatemia Clinical trials scenario. This report provides top line data relating to the...

Avitaminosis (Hypovitaminosis) Disease – Global Clinical Trials Review, H1, 2020

  • $2,500
  • June 2020
GlobalData's clinical trial report, “Avitaminosis (Hypovitaminosis) Global Clinical Trials Review, H1, 2020" provides an overview of Avitaminosis (Hypovitaminosis) Clinical trials scenario. This report provides top line data relating to the...